AI Stock Sell-Off: The 5 Best Stocks to Buy Right Now

TSMC projects a mid- to high-50% CAGR in AI chip revenue from 2024–2029; Broadcom expects custom AI chip sales to exceed $100B by 2027, and Nvidia forecasts global data-center capex of $3–$4T by 2030. Market sell-offs have left key AI hardware names discounted (TSMC ~15% below peak; Broadcom ~25% below peak) while hyperscalers delivered strong quarterly growth (Microsoft Azure +39%; Meta revenue +24%) despite share-price weakness. The article recommends buying Nvidia, Broadcom, TSM, Microsoft and Meta as multi-year AI spending should support earnings recovery, with near-term catalysts cited as upcoming earnings or de-escalation of the Iran conflict.

Analysis

AI compute demand is bifurcating winners: pure-play accelerator designers and foundries that can monetize capacity scarcity will capture oversized cashflow expansion, while integrated silicon/software conglomerates face more volatile multiple re-rating because their revenue mixes are less transparent. A second-order beneficiary chain—ASML/LRCX-style lithography and substrate/supply vendors, high-bandwidth memory makers, and liquid-cooling/PSU OEMs—should see margin tailwinds as hyperscalers accept premium pricing to unlock performance per rack.

Geopolitics and customer concentration are the primary path-dependent risks. A Taiwan-China escalation or even targeted export controls would create immediate supply shocks (weeks-to-months) that lift foundry pricing but strand designers reliant on one process node; conversely, a near-term slowdown in hyperscaler capex would show up as inventory digestion over 1–3 quarters before the secular AI demand reasserts itself.

From a positioning lens, asymmetric option structures dominate: buy-exposure to idiosyncratic winners while financing with limited-duration sells reduces theta bleed and trades the calendar of enterprise AI adoption. The consensus underprices the stickiness of hyperscaler procurement cycles (multi-year purchase commitments and bespoke silicon roadmaps), which implies that a handful of suppliers will outsizedly benefit for years even if headline sell-offs persist.

The contrarian risk is that Broadcom-like integrators can rehydrate multiples via recurring software/service margins from custom chips—if they convert recent wins into multi-year contracts, multiple compression will reverse quickly. That makes relative-value trades (long pure-play foundry/accelerator vs. short integrator-exposure) higher-probability than naked directional longs in the near term.

Key Decisions for Investors

• Long NVDA via 9–12 month call spread (buy 12-month ITM call, sell 9-month higher-strike call) — position size 1.5–3% NAV. Rationale: asymmetric upside if data-center spend reaccelerates; capped premium limits downside to <100% of paid premium. Target: 60–150% return on premium if NVDA reclaims growth multiple within 6–12 months; stop-loss: mark-to-market -50% on premium.
• Relative-value pair: Long TSM (2–3% NAV) / Short AVGO (1–1.5% NAV) — horizon 6–18 months. Rationale: TSM benefits from capacity tightness and equipment lead-times while Broadcom faces greater multiple risk from software/conglomerate sentiment. Target: 20–35% absolute on long or 15–25% relative outperformance; hard stop: 12% on long leg, 18% on short leg adverse move.
• Core hedgeable long MSFT (2–3% NAV) with 6-month protective puts (~3–4% of position cost) — horizon 6–12 months. Rationale: capture secular cloud/AI upside while limiting drawdown from macro-driven multiple compression. Target: 15–25% upside; cost of hedge acceptable as insurance vs 15–20% tail risk.
• Contrarian, longer-duration speculative: Buy INTC 12–24 month LEAP calls (or 18–24 month equity overweight 0.5–1% NAV) — horizon 12–24 months. Rationale: if Intel executes node remediation and secures AI accelerator wins, re-rating is underappreciated now. Risk/reward: binary — pay 100% premium on option but upside >3x if roadmap executes; cap allocation to small size given execution risk.